Evidence that MIG-6 is a tumor-suppressor gene

被引:0
|
作者
Y-W Zhang
B Staal
Y Su
P Swiatek
P Zhao
B Cao
J Resau
R Sigler
R Bronson
G F Vande Woude
机构
[1] Laboratory of Molecular Oncology,Division of Pfizer
[2] Van Andel Research Institute,Department of Pathology
[3] Laboratory of Germline Modification,undefined
[4] Van Andel Research Institute,undefined
[5] Laboratory of Antibody Technology,undefined
[6] Van Andel Research Institute,undefined
[7] Laboratory of Analytical,undefined
[8] Cellular,undefined
[9] and Molecular Microscopy,undefined
[10] Van Andel Research Institute,undefined
[11] Esperion Therapeutics,undefined
[12] Harvard Medical School,undefined
来源
Oncogene | 2007年 / 26卷
关键词
MIG-6; mutation; lung carcinogenesis; signal transduction; EGF; HGF/SF;
D O I
暂无
中图分类号
学科分类号
摘要
Mitogen-inducible gene 6 (MIG-6) is located in human chromosome 1p36, a locus frequently associated with human lung cancer. MIG-6 is a negative regulator of epidermal growth factor (EGF) signaling, and we show that Mig-6 – like EGF – is induced by hepatocyte growth factor/scatter factor (HGF/SF) in human lung cancer cell lines. Frequently, the receptors for both factors, EGFR and Met, are expressed in same lung cancer cell line, and MIG-6 is induced by both factors in a mitogen-activated protein kinase-dependent fashion. However, not all tumor lines express MIG-6 in response to either EGF or HGF/SF. In these cases, we find missense and nonsense mutations in the MIG-6 coding region, as well as evidence for MIG-6 transcriptional silencing. Moreover, germline disruption of Mig-6 in mice leads to the development of animals with epithelial hyperplasia, adenoma, and adenocarcinoma in organs like the lung, gallbladder, and bile duct. These data suggests that MIG-6 is a tumor-suppressor gene and is therefore a candidate gene for the frequent 1p36 genetic alterations found in lung cancer.
引用
收藏
页码:269 / 276
页数:7
相关论文
共 50 条
  • [1] Evidence that MIG-6 is a tumor-suppressor gene
    Zhang, Y-W
    Staal, B.
    Su, Y.
    Swiatek, P.
    Zhao, P.
    Cao, B.
    Resau, J.
    Sigler, R.
    Bronson, R.
    Vande Woude, G. F.
    ONCOGENE, 2007, 26 (02) : 269 - 276
  • [2] The role of Mig-6 as a tumor suppressor in metastatic and recurrent endometrial cancer
    Tae Hoon Kim
    Marquardt, Ryan M.
    Broaddus, Russell R.
    Jeong, Jae-Wook
    CANCER RESEARCH, 2020, 80 (16)
  • [3] Epithelial Mig-6 is critical for a tumor suppressor function in endometrial cancer
    Kim, Tae Hoon
    Choi, Sung Nam
    Large, Michael J.
    Broaddus, Russell R.
    Orvis, Grant D.
    Behringer, Richard R.
    Jeong, Jae-Wook
    CANCER RESEARCH, 2011, 71
  • [4] Critical Tumor Suppressor Function Mediated by Epithelial Mig-6 in Endometrial Cancer
    Kim, Tae Hoon
    Lee, Dong-Kee
    Cho, Sung-Nam
    Orvis, Grant D.
    Behringer, Richard R.
    Lydon, John P.
    Ku, Bon Jeong
    McCampbell, Adrienne S.
    Broaddus, Russell R.
    Jeong, Jae-Wook
    CANCER RESEARCH, 2013, 73 (16) : 5090 - 5099
  • [5] EVIDENCE FOR A NEW TUMOR-SUPPRESSOR GENE INVOLVED IN GASTROINTESTINAL MALIGNANCIES
    WASYLYSHYN, ML
    NEUMAN, WL
    ANGRIMAN, I
    SNYDER, LA
    MONTAG, AG
    WESTBROOK, CA
    MICHELASSI, F
    SURGERY, 1991, 110 (02) : 265 - 269
  • [6] BLID: A Novel Tumor-Suppressor Gene
    Yu, Xin
    Li, Zheng
    ONCOLOGY RESEARCH, 2015, 22 (5-6) : 333 - 338
  • [7] TUMOR-SUPPRESSOR GENE CONCEPT OF CARCINOGENESIS
    WUNDERLICH, V
    RAJEWSKY, MF
    LANCET, 1995, 345 (8964): : 1570 - 1571
  • [8] Evaluating tumor-suppressor gene combinations
    James Kim
    John D. Minna
    Nature Genetics, 2018, 50 : 480 - 482
  • [9] Evaluating tumor-suppressor gene combinations
    Kim, James
    Minna, John D.
    NATURE GENETICS, 2018, 50 (04) : 480 - 482
  • [10] 6 MICROSATELLITE POLYMORPHISMS AT CANDIDATE AND CONFIRMED TUMOR-SUPPRESSOR GENE LOCI
    JONES, MH
    SATO, T
    SAITO, H
    TANIGAMI, A
    NAKAMURA, Y
    HUMAN MOLECULAR GENETICS, 1994, 3 (10) : 1911 - 1911